Lashev, L., 2017. Allometric analysis of the pharmacokinetics of four cephalosporin antibiotics in mammals. Bulg. J. Vet. Med., 20, No 1,[27][28][29][30][31][32][33][34][35][36][37] Allometric analysis of the total body clearance (Cl B ), steady-state volume of distribution (V ss ) and elimination half-life (t 1/2 ) was performed for cephalexin, cefepime, cefquinone and ceftriaxone based on literature data in mammalian species. Values of Cl B and V ss show allometric dependence on body weight, while values of t 1/2 could not be predicted correctly after scaling toward body weight. The equations based on the calculations which could be used for estimation of the respective pharmacokinetic parameters are as follows: Cephalexin: Cl B =0.20W 
INTRODUCTION
Allometric analysis is a method for predicting the values of some pharmacokinetic parameters of drugs and to estimate dosage regimens in animal species that have not been studied so far. It has also been used in drug development (Mahmood & Balian, 1999) and for comparison of pharmacokinetic characteristics of different substances among species (Dinev, 2008) . The allometric scaling is usually conducted using data for animal species, belonging to taxonomic groups with similar physiological characteristics as birds or mammals (herbivores or carnivores) (Pashov et al., 1997; Dinev, 2008; Haritova & Lashev, 2009; . This is based on interspecies differences in the physiology and it is aimed at predicting the specific pharmacokinetic properties of the drugs with high accuracy. Comparative interspecies pharmacokinetic scaling has been performed for a large variety of antibacterial agents (Riviere et al., 1997; Cox, 2007; Lashev & Haritova, 2007; Haritova & Lashev, 2009; Hunter, 2010) but not for cephalosporin antibiotics. The latter are widely used for treatment of different infections in veterinary and hu-man medicine. Their pharmacokinetics is extensively studied in a number of animal species after different routes of administration. These drugs have a similar distribution and differ mainly in elimination phase and especially in elimination rates depending on the species and age (Smiet et al., 2012) . Considerable variations are registered after oral absorption. Cephalosporins have a volume of distribution between 0.2 and 0.5 L/kg. Binding to plasma proteins varies among the substances and species, but often has low values. Cephalosporins are metabolised at a very low extent with the exception of ceftiofur (Mordenti, 1985) . The major differences between animal species are related to active transport and renal excretion. These drugs are excreted with urine mainly by tubular secretion (Forgue et al., 1987) .
The objective of this study was to assess the relationships between elimination half-life, volume of distribution at steadystate, and total body clearance to body weight of four cephalosporins, used in veterinary medicine, in mammalian species by means of allometric scaling.
MATERIALS AND METHODS
The allometric analysis of pharmacokinetic parameters of cephalexin, cefquinome, ceftriaxone and cefepime was performed with data from published studies concerning healthy adult animals (Tables  1−4 ). Only data for intravenously administered drugs, determined by microbiological or HPLC assays, were used. The matrices of interest were serum or plasma. For analysis of each drug, data for elimination half-life (t 1/2β ), volume of distribution at steady-state (V ss ) and total body clearance (Cl B ) were used. Data for body weights were collected from the same studies. All values were calculated on the basis of mean published values of pharmacokinetic parameters versus body weights of the included animals. The simple allometric approach was based on the following power function: 
RESULTS
The results from the regression analysis are listed in Table 5 . The values of the exponent b for t 1/2β were lower than the theoretical value of 0.25 for all four cephalosporins. The value for cephalexin was even negative. The correlation between t 1/2β values and body weight were statistically significant only for cefepime and ceftriaxone. The highest value of yintercept (a) for t 1/2β was calculated for cephalexin (1.45) and the lowest for cefquinome (0.65). The values of b for V ss and Cl B ranged between 0.79 and 0.99, respectively 0.68 and 1.05 for all studied drugs. Statistically significant relationship was found between body weight and V ss 
DISCUSSION
Simple allometric scaling is an attractive alternative to provide reliable predictions of t 1/2β , V ss and Cl B . Despite the risk of deviation of estimated values from the observed pharmacokinetic parameters in some cases, interspecies scaling could be used to analyse the pharmacokinetic behaviour of drugs in veterinary medicine, it provides good explanations for the observed differences between animal species (Mahmood, 2007) . The experience with allometric scaling shows that after inclusion of large number of analysed data (from as many as possible animal species Haritova & Lashev (2012) . a -allometric coefficient, b -allometric exponent, r -correlation coefficient, P -level of significance.
as well as individual studies for each species) the method can provide precise values of estimated parameters (Mahmood & Balian, 1999; Mahmood, 2007) . Results of previous studies confirm this observation. Therefore, in the present study, as many as possible data reported in the literature were used. Dividing animal species in groups according to their physiological characteristics additionally improves the predictive power (Mahmood, 2007) . For example, the excretion function of kidneys, which is important for the elimination rate of cephalosporins, is different in mammals than in birds. These differences lead to less correct estimations of pharmacokinetic parameters by allometric scaling analysis. That is why only data for mammalian species were included in the present calculations. The examined cephalosporin antibiotics have similar pharmacokinetic properties -low level of distributions and fast elimination. They are not metabolised in the organism and are eliminated mainly by renal excretion in the urine, which makes allometric scaling valuable (Mahmood, 2007; Hunter et al., 2008) . The allometric exponent b for pharmacokinetic parameters, such as body clearance and volume of distribution, related to physiological processes ranges from 0.67 to 1 (Riviere et al., 1997) . The theoretical value for the volume of distribution is 1 assuming that total body water directly correlates to body weight and the volume of distribution is a function of total body water. Our results for the analysed substances are close to the theoretical. Theoretical value of allometric exponent b for volume of distribution (V ss ) is equal to 1. Our results for cephalosporins in mammals are very close to 1, with high correlation coefficient and low P-value, which allow us accepting that V ss correlates with body weight. This pharmacokinetic parameter could be predicted successfully for investigated cefalosporins. It is widely accepted that the metabolic rate is propotional to body mass raised to the three-quarter power (W 0.75 ). The overall renal and hepatic functions are related to blood flow, which is dependent on car- diac output, scaled to b equal to 0.75. This is true especially for drugs that did not undergo significant metabolic conversion (Mahmood & Balian, 1999; Mahmood, 2007) . Our values of b for total body clearance vary between 0.68 and 1. This could be explaned by the chemical properties of substances, number of species included, variations in experimental design, and inter-laboratory variability. In any case the values of b do not differ statistically from the theoretical value of 0.75. The presented data are close to the reported for ceftiofur (Haritova & Lashev, 2012) . Grouping of animal species in clusters according to their affiliation to different orders improves allometric scaling as it has been demonstrated in previous investigations (Kirkwood & Merriam, 1990; Mahmood, 2007; Haritova & Lashev, 2009 ). The findings of Hunter et al. (2008) suggest that better prediction of the pharmacokinetic parameters and dosage regimen for birds are generated when using only avian data and that improvements in prediction are seen in drugs that are renally excreted. Ideally, one should scale values of Cl B for compounds that are excreted, without metabolism through kidneys. In the current study we dealt with drugs that are metabolised at a low extent. The exponent 0.75 was widely applied for Cl B but it is based on basal metabolic rate and usage of this fixed value can result in wrong predictions (Mahmood, 2007) . According to Mahmood & Balian (1999) b values between 0.7 and 1 allow for a relatively proper prediction of Cl B .
The most difficult for successful scaling are the values of t 1/2 (Mahmood, 2007; Hunter et al., 2008) . As a secondary parameter it is derived from scaling to V ss /Cl B . In case of perfect correlation between body weight and last two parameters, value of b for t 1/2 would approximate to 0.25. Such case has been reported for quinolones in mammals and birds where b was lower than 0.25 (Cox et al., 2004; Cox, 2007; Haritova & Lashev, 2009 ). The same was registered for the investigated five cephalosporins (including ceftiofur). So our calculations showed lack (cephalexin and cefquinome) or presence of low association (cefepime and ceftriaxone) between t 1/2β values and body weight for all analysed substances.
The majority of calculated values are sufficiently close to the experimental. Exceptions are the values of cephalexin clearance in cows and buffaloes and the volume of distribution in goats. Different cefepime clearance is observed in monkeys and volume of distribution: in dogs, rabbits, goats and camels. For cefquinome the differences in clearance values are in sheep, goats and buffaloes, while for ceftriaxone -in mice, goats, horses. The volume of distribution of ceftriaxone was different in mice.
In conclusion, the values of Cl B and V ss of cephalexin, cefepime, cefquinome, ceftriaxone show significant correlation with the body weight of mammals. The values of the respective coefficient b are close to the theoretical ones. Such relationships for t 1/2β were detected only for cefepime and ceftriaxone, but not for cephalexin and cefquinome. The ratios between the calculated and experimental values for included cephalosporins varied at a different extent. For some species they are different from 1 (lower or higher). These variations are related also to the influence of various factors such as animal breed or methodological differences. They are not a reason to accept discussed relationships as invalid. These differences can be interpreted rather as criteria for the objectivity of the experimental data included in the calculations. The published findings could be used for prediction of pharmacokinetic parameters in rare wild and exotic species or for firstin-animal dose selection. 
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